MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Impact of a holistic and interdisciplinary care for patients with Parkinson’s disease – Cologne Parkinson’s network. Results of a randomized study with subanalysis

    R.A. Dano, J. Schill, L. Rochhausen, K. Williamson, L. Timmermann, C. Eggers (Cologne, Germany)

  • Impact of autonomic dysfunction on disease progression and survival in Parkinson’s disease

    E. De Pablo-Fernandez, C. Tur, T. Revesz, J.L. Holton, T.T. Warner (London, United Kingdom)

  • Impact of behavioral side effects on the management of Parkinson patients treated with dopamine agonists

    M.E. Mohammad, J.A. Vizcarra, K. O'Donnell, S. Patel, X. Garcia, X.X. Yu, K. Vlastaris, K. Sutton, H.H. Fernandez (Cleveland, OH, USA)

  • Impact of cardiovascular risk factors in the evolution and treatment of Parkinson’s disease in Mexican population

    G. Parra-López, L. Bazán-Rodríguez, M. Rodríguez-Violante, A. Cervantes-Arriaga, A. Jorge-de Sarachaga, D. Cruz-Fino, J. Pascacio-Astudillo, R. Llorens-Arenas (Mexico City, Mexico)

  • Impact of chronic LD treatment on metabolism, blood flow and blood-brain barrier permeability in the 6-OHDA rat model

    R.P. Lerner, Z. Bimpisidis, V. Jourdain, T. Chaly, M. Hellman, K. Graf, V. Dhawan, S. Dewey, A. Cenci, D. Eidelberg (Manhasset, NY, USA)

  • Impact of comorbidities and compliance initiatives in management of patients with early Parkinson’s disease

    A.V. Shalaeva, N.A. Dadabaeva, R.M. Allanov, M.B. Bozorboev, E. Shalaeva (Tashkent, Uzbekistan)

  • Impact of datscan on clinical decision making: diagnosis and management of clinically uncertain Parkinsonian syndromes

    J.R. Isaacson, N. Chhabria, S.H. Isaacson (Boca Raton, FL, USA)

  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson’s patients

    T.E. Tong, M.L. Ng, N. Yan (Hong Kong, Hong Kong)

  • Impact of neurogenic orthostatic hypotension on healthcare utilization and costs associated with falls in Parkinson’s disease

    C. Francois, I. Biaggioni, C.A. Shibao, A. Ogbonnaya, H.C. Shih, E. Farrelly, A. Ziemann, A. Duhig (Deerfield, IL, USA)

  • Impact of pre- and postdiagnosis physical activity on the progression of Parkinson’s disease

    I.F. Shih, K.C. Paul, Y. Bordelon, J.M. Bronstein, B. Ritz (Los Angeles, CA, USA)

  • « Previous Page
  • 1
  • …
  • 96
  • 97
  • 98
  • 99
  • 100
  • …
  • 207
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley